Dr. Robert A. Nagourney, MD
“New” Immune Therapy Active in Late-Stage Cancer Patients
Here in 2023, we
suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.
top of page
Cancer Blog
- Dr. Robert Nagourney -
Search
Dr. Robert A. Nagourney, MD
- Jul 24
- 2 min
Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good
There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.
Dr. Robert A. Nagourney, MD
- Jun 26
- 3 min
Challenging Paradigms: The Management of Rectal Cancer
One noteworthy case was a 78-year-old patient successfully treated without surgery.
Dr. Robert A. Nagourney, MD
- Jun 2
- 2 min
Breakthrough for Young Patients with a Rare Form of Liver Cancer
Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.
Dr. Robert A. Nagourney, MD
- May 19
- 3 min
For Medical Oncology, Déjà Vu All Over Again
Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.
Dr. Robert A. Nagourney, MD
- May 15
- 4 min
Nagourney Cancer Institute: 20-year Experience in 10,000 Patients
At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.
Dr. Robert A. Nagourney, MD
- Mar 27
- 2 min
Benefits of Combining Functional Profiling with Nagourney Cancer Institute's 11,000 Patient Studies
Combining Functional Profiling with Nagourney Cancer Institute's 11,000 patient studies provides personalized cancer treatment plans.
Dr. Robert A. Nagourney, MD
- Feb 15
- 2 min
Functional Profiling vs. Functional Medicine: What’s the Difference?
We take a different approach to the treatment of cancer – based on profiling how our patients’ cancerous cells will respond to treatment.
Dr. Robert A. Nagourney, MD
- Jan 30
- 3 min
Treatment for Stage 4 Pancreatic Cancer May Be at Hand
After the recommended treatment, FOLFIRINOX, using his tissue we suggested new classes of drugs that target P53 and MEK/ERK.
Dr. Robert A. Nagourney, MD
- Dec 30, 2022
- 2 min
A Year-End Reflection
2022 Reflection. Among our most important accomplishments in 2022 was the installation of a world-class Mass Spectrometry research program.
Dr. Robert A. Nagourney, MD
- Nov 29, 2022
- 2 min
Lung Cancer Patients Need More Than a Lungmap to Nowhere
I applaud anything that accelerates clinical development, but once again the focus is almost exclusively genomic.
Dr. Robert A. Nagourney, MD
- Oct 17, 2022
- 3 min
Do Rare Tumors Hold The Key To Future Cancer Cures?
Can rare tumors offer the way forward? This optimism comes from the fact that not unlike CML, rare cancers may carry unique insights.
Dr. Robert A. Nagourney, MD
- Oct 13, 2022
- 2 min
Fibrolamellar Cancer Foundation Symposium September 29, 2022
Fibrolamellar cancer (FLC) is a rare tumor of adolescents and young adults occurring 1 in 5 million that arises as a large mass in the live
Dr. Robert A. Nagourney, MD
- Sep 20, 2022
- 2 min
Do The Mutations That Drive Cancer Actually Affect Immunity?
A study in the journal Oncogene finds that pancreatic cancer may progress as a result of the loss of normal immune response. (source: ...
Dr. Robert A. Nagourney, MD
- Oct 21, 2013
- 4 min
The Information Disconnect - Genomics vs Human Cancer Biology
I recently had an interesting conversation with a physician regarding her patient with an aggressive breast cancer. A portion of tumor...
Dr. Robert A. Nagourney, MD
- Jul 9, 2013
- 3 min
Functional Profiling Identifies Accurate Genomic Findings
The 2013 American Society of Clinical Oncology annual meeting, held May 31 – June 1, in Chicago, afforded the opportunity to report three...
Dr. Robert A. Nagourney, MD
- May 20, 2013
- 2 min
Personalized Cancer Care: N-of-1
The New York Yankees catcher Yogi Berra famous quote, “Déjà vu all over again,” reminds me of the growing focus on the concept of “N-...
Dr. Robert A. Nagourney, MD
- Apr 25, 2013
- 3 min
The Future of Cancer Research
The American Association for Cancer Research meeting held April 6 - 10 in Washington DC, provided a scientific perspective on oncologic...
Dr. Robert A. Nagourney, MD
- Apr 19, 2013
- 1 min
Cancer as a Metabolic Disorder
I received an inquiry via Twitter “Has anyone thought about using a sugar medium (similar to PET scans) to deliver chemo drugs?” Although...
bottom of page